A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT02254434 · COMPLETED

Trial details

NCT number: NCT02254434
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cirrhosis, Liver

Start date: 2014-08-28
Primary completion: 2014-09-08
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.